ABCG5 and Macrothrombocytopenia: In the course of the evaluation, ABCG5 heterozygosity was identified as a cause of autosomal dominant inherited macrothrombocytopenia; the role of ABCG5 in macrothrombocytopenia and its therapy with Ezetimibe should be further investigated.